• Personalis obtained Class A CE-IVD marking under the EU IVDR for its EDTA blood collection kit and cfDNA blood collection kit.
• The clearance enables use of the kits at clinical trial sites across the EU and Great Britain, supporting global deployment of its NeXT Personal MRD test.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Personalis Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202606090600BIZWIRE_USPR_____20260609_BW549732) on June 09, 2026, and is solely responsible for the information contained therein.